Efficacy of Pulsed Electromagnetic Field Therapy on Acute Radiodermatitis in Breast Cancer Patients

Last updated: September 3, 2024
Sponsor: Ahram Canadian University
Overall Status: Completed

Phase

N/A

Condition

Eczema (Atopic Dermatitis - Pediatric)

Allergy

Rash

Treatment

Pulsed electromagnetic field

traditional skin care

Clinical Study ID

NCT06003764
AhramCU
  • Ages 35-55
  • Female

Study Summary

This study aims to evaluate the impact of PEMF on acute radiodermatitis in breast cancer patient and post mastectomy patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Breast cancer patients undergoing HF-WBI post-lumpectomy with or withoutchemotherapy.

  • Unilateral breast cancer

  • Age from 35-55 years.

Exclusion

Exclusion Criteria:

  • Patients had previous irradiation to the same breast.

  • Patients had bilateral breast cancer.

  • Patients had metastatic disease.

  • when the use of bolus material was required to deliver RT.

  • Patients had a pre-existing skin condition or open wound in the treatment area.

Study Design

Total Participants: 50
Treatment Group(s): 2
Primary Treatment: Pulsed electromagnetic field
Phase:
Study Start date:
November 01, 2023
Estimated Completion Date:
July 10, 2024

Study Description

The objective is to understand the effect of PEMF on skin thickness and toxicity after radiotherapy on breast cancer.

The study included 50 adult female breast cancer undergoing whole-breast irradiation.

This is a randomized, controlled clinical trial was conducted at the outpatient clinic of the Faculty of Physical Therapy, Ahram Canadian University, Egypt.

Connect with a study center

  • ahram canadian University

    Giza,
    Egypt

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.